Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

10/05/2017 ​Barcelona Synchrotron Park’s Commitment to Nature and Biodiversity 04/05/2017 ​Reference research centres in the environment of the Barcelona Synchrotron Park 27/04/2017 ​SMEs discover the potential of the Barcelona Synchrotron Park 18/04/2017 ​Stradivarius has settled in the Barcelona Synchrotron Park 05/04/2017 The BSP is candidate to host the European Medicines Agency 30/03/2017 ALBA Synchrotron Gives Support to Companies
17 18 19 20 21 22 23 24 25 26 27